Oz Biosciences

Oz Biosciences

Oz Biosciences, established in 2003, develops cutting-edge transfection and transduction reagents for in vitro and in vivo biomolecule delivery. Oz has achieved a strong position in the field of molecular delivery systems with their innovative systems of Magnetofection™, a transfection method based on magnetic nanoparticles, Lipofection, a lipid-based transfection technology using biochemical methods, and Polyfection, a polymer-based transfection technology. Oz’s range of reagents includes specialized tools for CRISPR, stem cell applications, cell-specific reagents, and much more. Oz also provides vectors for achieving high levels of transgene expression. With these tools, transfection and transduction efficiency and performance is greatly improved.

Recently Viewed Products